Edwards Lifesciences target price raised to $121 from $113
EW•Wells Fargo raised its target price for Edwards Lifesciences to $121 from $113.
Related News

Haoxin Holdings holds extraordinary general meeting of shareholders
HXHX•

Shinhan Financial Group swings to three-month separate net profit of KRW 2.98 billion
SHG•

Oscar Health appoints Tomer Cohen, Eric Larsen and Rajat Taneja to board
OSCR•

AECOM appoints James Atha to lead executive architecture in UK and Ireland
ACM•

Cousins Properties raises target price to $35 from $34
CUZ•